Abstract:Cystic fibrosis (CF) is the most common lethal autosomal recessive disease in the white population. Mutation of the CF transmembrane conductance regulator gene on chromosome 7 results in production of abnormally viscous mucus and secretions in the lungs of patients with CF. A similar pathologic process occurs in the gastrointestinal tract, pancreas, and hepatobiliary system. Inspissated mucus causes luminal obstruction and resultant clinical and radiologic complications associated with the disease process. Pancreatic involvement can result in exocrine and endocrine insufficiency, pancreatic atrophy, fatty replacement, or lipomatous pseudohypertrophy. Acute and chronic pancreatitis, pancreatic calcification, cysts, and cystosis also occur. Hepatic manifestations include hepatic steatosis, focal biliary and multilobular cirrhosis, and portal hypertension. Biliary complications include cholelithiasis, microgallbladder, and sclerosing cholangitis. The entire digestive tract can be involved. Distal ileal obstruction syndrome, intussusception, appendicitis, chronic constipation, colonic wall thickening, fibrosing colonopathy, pneumatosis intestinalis, gastroesophageal reflux, and peptic ulcer disease have been described. Renal manifestations include nephrolithiasis and secondary amyloidosis. The educational objectives of this review are to reveal the abdominal manifestations of CF to facilitate focused analysis of cross-sectional imaging in adult patients. Life expectancy in patients with CF continues to improve because of a combination of aggressive antibiotic treatment, improved emphasis on nutrition and physiotherapy, and development of promising new CF transmembrane conductance regulator modulators. As lung function and survival improve, extrapulmonary conditions, including hepatic and gastrointestinal malignancy, will be an increasing cause of morbidity and mortality. Awareness of the expected abdominal manifestations of CF may assist radiologists in identifying acute inflammatory or neoplastic conditions. (©)RSNA, 2015.

Pathophysiology of cystic fibrosis with emphasis on salivary gland involvement

Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease.

Submucosal gland dysfunction as a primary defect in cystic fibrosis.

Cystic fibrosis: lessons from the sweat gland

Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets

Rationale for Hypertonic Saline Therapy for Cystic Fibrosis Lung Disease

Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis.

Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis

Cystic Fibrosis Lung Disease: An Overview

Pulmonary Vascular Dysfunctions in Cystic Fibrosis

Mucus, phlegm, and sputum in cystic fibrosis

Fluid secretion by submucosal glands of the tracheobronchial airways

CFTR dysfunction leads to defective bacterial eradication on cystic fibrosis airways

Epigenetic Regulation of CFTR in Salivary Gland.

The Clinical Biology of Cystic Fibrosis Transmembrane Regulator Protein: Its Role and Function in Extrapulmonary Disease

Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy

Cystic Fibrosis below the Diaphragm: Abdominal Findings in Adult Patients

Molecular Mechanisms of Staphylococcus and Pseudomonas Interactions in Cystic Fibrosis

Targeting Proteases in Cystic Fibrosis Lung Disease: Paradigms, Progress, and Potential.

Pathophysiology of Cystic Fibrosis Liver Disease

Metabolic alkalosis in cystic fibrosis: from vascular volume depletion to impaired bicarbonate excretion